BlackRock Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.09M | Sell |
52,128
-13,501
| -21% | -$281K | ﹤0.01% | 2089 |
|
|
2016
Q3 | $2.15M | Buy |
65,629
+6,916
| +12% | +$227K | ﹤0.01% | 1564 |
|
|
2016
Q2 | $1.47M | Sell |
58,713
-11,783
| -17% | -$294K | ﹤0.01% | 1743 |
|
|
2016
Q1 | $1.73M | Sell |
70,496
-224,882
| -76% | -$5.51M | ﹤0.01% | 1627 |
|
|
2015
Q4 | $9.76M | Sell |
295,378
-4,523
| -2% | -$149K | 0.01% | 924 |
|
|
2015
Q3 | $9.83M | Sell |
299,901
-37,023
| -11% | -$1.21M | 0.01% | 925 |
|
|
2015
Q2 | $17.8M | Buy |
336,924
+17,126
| +5% | +$907K | 0.01% | 833 |
|
|
2015
Q1 | $9.23M | Buy |
319,798
+175,098
| +121% | +$5.05M | 0.01% | 978 |
|
|
2014
Q4 | $4.21M | Sell |
144,700
-6,386
| -4% | -$186K | ﹤0.01% | 1171 |
|
|
2014
Q3 | $1.92M | Sell |
151,086
-18,745
| -11% | -$238K | ﹤0.01% | 1420 |
|
|
2014
Q2 | $3.41M | Buy |
+169,831
| New | +$3.41M | ﹤0.01% | 1239 |
|